These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8095455)

  • 1. Effects of ibopamine on renal haemodynamics in patients with severe congestive heart failure.
    Girbes AR; Kalisvaart CJ; Van Veldhuisen DJ; Tan ET; Smit AJ; Reitsma WD; Pasteuning WH
    Eur Heart J; 1993 Feb; 14(2):279-83. PubMed ID: 8095455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure.
    Lieverse AG; Girbes AR; Van Veldhuisen DJ; Smit AJ; Zijlstra JG; Meijer S; Lie KI; Reitsma WD
    Eur Heart J; 1995 Jul; 16(7):937-42. PubMed ID: 7498209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and neurohumoral effects of ibopamine and metoclopramide in normal man.
    Girbes AR; van Veldhuisen DJ; Smit AJ; Drent-Bremer A; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1991 Jun; 31(6):701-4. PubMed ID: 1678273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.
    Lieverse AG; van Veldhuisen DJ; Smit AJ; Zijlstra JG; Meijer S; Reitsma WD; Lie KI; Girbes AR
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):361-7. PubMed ID: 7769799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibopamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in congestive heart failure.
    Spencer C; Faulds D; Fitton A
    Drugs Aging; 1993; 3(6):556-84. PubMed ID: 7906158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis.
    Salerno F; Incerti P; Badalamenti S; Lorenzano E; Graziani G; Morganti A; Ghirardi P
    Arch Intern Med; 1990 Jan; 150(1):65-9. PubMed ID: 1967522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs.
    Marchetti GV
    Cardiology; 1990; 77 Suppl 5():22-9. PubMed ID: 1980631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ibopamine in congestive heart failure.
    van Veldhuisen DJ; Girbes AR; Crijns HJ; Smit AJ; de Graeff PA; Lie KI
    J Auton Pharmacol; 1990; 10 Suppl 1():s115-21. PubMed ID: 1983005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and renal effects of ibopamine in normal subjects.
    Incerti PL; Badalamenti S; Lorenzano E; Graziani G; Morganti A; Salerno F; Ghirardi P
    Arzneimittelforschung; 1986 Feb; 36(2A):405-7. PubMed ID: 3518727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial.
    Wehling M; Zimmermann J; Theisen K
    Cardiology; 1990; 77 Suppl 5():81-8. PubMed ID: 2279257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
    van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Lok DJ; Dohmen HJ; Poortermans JC; Withagen AJ; Pasteuning WH; Brouwer J; Lie KI
    J Am Coll Cardiol; 1993 Nov; 22(6):1564-73. PubMed ID: 7901256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive evaluation of the effects of oral ibopamine (SB 7505) on cardiac and renal function in patients with congestive heart failure.
    Dei Cas L; Manca C; Bernardini B; Vasini G; Visioli O
    J Cardiovasc Pharmacol; 1982; 4(3):436-40. PubMed ID: 6177940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
    Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
    Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
    G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.
    Van Veldhuisen DJ; Crijns HJ; Girbes AR; Tobé TJ; Wiesfeld AC; Lie KI
    Am J Cardiol; 1991 Nov; 68(11):1194-202. PubMed ID: 1683146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
    Metra M; Missale C; Spano PF; Cas LD
    J Cardiovasc Pharmacol; 1995 May; 25(5):732-40. PubMed ID: 7630152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
    Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.